Mike Jacobs is headed for the history books for all the wrong reasons. (Mark Duncan/AP)

Jacobs is the first professional baseball player, and first professional athlete in North America, according to ESPN, to test positive for human growth hormone (HGH). Following the failed drug test Jacobs was immediately given a 50-game suspension from the Class AAA Rockies affiliate Colorado Springs Sky Sox.

Jacobs, 30, apologized for his use of the banned substance in a statement, saying:

“A few weeks ago, in an attempt to overcome knee and back problems, I made the terrible decision to take HGH. I immediately stopped a couple of days later after being tested. Taking it was one of the worst decisions I could have ever made, one for which I take full responsibility. I apologize to my family, friends, the Colorado Rockies organization, Major League Baseball and to the fans. Now, as required by the minor league drug program, I will serve a 50-game suspension. After my suspension is completed, I hope to have the opportunity to continue my career in the game that I love so much.”

Mike Jacobs was batting .298 with 23 home runs and a record 97 RBIs for the Sky Sox, and has his sights set on regaining a spot in the majors before his suspension. “I’m trying to show baseball people that I don’t belong in Triple-A,” Jacobs stated in a recent article in The Denver Post. “There are times when you think you’ve been forgotten. I want an opportunity to be remembered, if not with the Rockies, with another big-league team.”

The Colorado Rockies released Jacobs Thursday after he was suspended, and released a statement supporting the MLB’s ruling.

“We were very disappointed to learn that Mike Jacobs had been suspended after testing positive for a performance-enhancing substance. The Colorado Rockies have long been committed to eliminating the use of performance-enhancing substances from the game of baseball. We have fully supported the adoption and implementation of the Major League Baseball and the Major League Baseball Players Association joint drug prevention and treatment program.”